Meta Biomed Co., Ltd. (KOSDAQ: 059210)
South Korea
· Delayed Price · Currency is KRW
4,120.00
-10.00 (-0.24%)
Jan 22, 2025, 3:00 PM KST
Meta Biomed Revenue
Meta Biomed had revenue of 23.15B KRW in the quarter ending September 30, 2024, with 10.55% growth. This brings the company's revenue in the last twelve months to 92.30B, up 16.03% year-over-year. In the year 2023, Meta Biomed had annual revenue of 83.10B with 20.54% growth.
Revenue (ttm)
92.30B
Revenue Growth
+16.03%
P/S Ratio
1.02
Revenue / Employee
340.59M
Employees
271
Market Cap
94.23B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 83.10B | 14.16B | 20.54% |
Dec 31, 2022 | 68.94B | 10.16B | 17.29% |
Dec 31, 2021 | 58.78B | 13.78B | 30.63% |
Dec 31, 2020 | 45.00B | -14.39B | -24.24% |
Dec 31, 2019 | 59.39B | 6.81B | 12.94% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 292.86T |
SK hynix | 57.73T |
LG Energy Solution | 27.17T |
Samsung Biologics Co.,Ltd. | 4,364.39B |
Hyundai Motor Company | 170.28T |
Kia Corporation | 104.63T |
Celltrion | 2,876.25B |
KB Financial Group | 14.11T |